Background: Cardiac magnetic resonance imaging (MRI) is a commonly used modality to help differentiate patients with right ventricular outflow tract (RVOT) tachycardia and those with arrhythmogenic right ventricular dysplasia (ARVD). Both of these groups of patients present with monomorphic ventricular tachycardia (VT) arising from the right ventricle. Methods and Results: Patients were diagnosed with ARVD and RVOT tachycardia using standard clinical criteria. Thirteen ARVD patients underwent cardiac MRI; 5 had normal scans and 8 had findings suggestive of ARVD (including fatty infiltration, fibrosis, and right ventricular wall thinning, hypokinesis, or dyskinesis). Thirty-seven patients with RVOT tachycardia underwent cardiac MRI; of these 26 were normal and 11 were abnormal. Therefore, the positivity rate of MRI was 62% in ARVD pts, and the negativity rate in RVOT pts was 30%. Conclusions: These findings suggest that abnormalities of the right ventricle seen on cardiac MRI appear to be nonspecific for ARVD. In addition, the sensitivity of MRI imaging in detecting patients with ARVD is suboptimal, as these pts not uncommonly have normal or only mildly abnormal cardiac MRI scans, especially early in the disease process.
1130-226 Surface Electrocardiogram Clues to Localization of Ventricular Tachycardia to the Aortic Cusps
David Lin, Stuart J. Beldner, Ward Pulliam, Sultan Siddique, Erica S. Zado, Sanjay S. Dixit, David J. Callans, Francis E. Marchlinski, University of Pennsylvania Health System, Philadelphia, PA Background Repetitive monomorphic ventricular tachycardia (VT) occurring in the absence of structural heart disease typically originates in the outflow tract regions of the right and less commonly the left ventricles. The ECG pattern for VT originating from right ventricular outflow tract has been well described. However, a site of origin from the coronary cusps has not been well documented and may be more common than previously recognized. This study identifies surface electrocardiographic clues that suggest VT originating from the aortic cusps. Methods A total of 8 patients undergoing ablation for VT had detailed (>150 points) 3D electromagnetic mapping (MEAM) and pacemapping performed from the aortic cusps and from the endocardial aortomitral continuity (AMC) at threshold. The sites were identified and tagged using MEAM, and confirmed by fluoroscopy and/or intracardiac echocardiography. The surface electrocardiograms (ECGs) were analyzed with pacing from each of the left (LC) and right (RC) aortic valve cusps as well as the AMC. The QRS morphology was recorded on the Prucka TM system at a sweep speed of 100 msec and analyzed offline.
Results
The mean QRS duration for LC pacing was 143msec (range 125-161msec), RC was 140msec (range 108-168msec), and AMC was 141msec (range 120-176msec). Lead V1 was found to be the most useful in distinguishing the different sites. LC pacing uniformly produced a typical "m" or "w" shaped multiphasic pattern in V1, AMC pacing demonstrated a qR pattern in V1, and RC pacing demonstrated a qS type of pattern in V1. The R wave transition occurred earlier (ie by V2 in 8 of 8 patients) with LC and AMC pacing than with RC pacing (by V3 or V4 in 6 of 8 patients and by V2 in only 2 patients). Discussion VT originating from the right and left aortic cusps and the adjacent endocardial aortomitral continuity have distinct patterns on the 12-lead ECG that can be useful in identifying the probable location of the VT and therefore the region to target for ablative therapy. Background: The presence of elevated cardiac enzymes after spontaneous implantable defibrillator (ICD) discharges is frequently attributed to the shocks delivered. We tested the hypothesis that the less specific cardiac enzymes CK and CK-MB would be related to number of ICD shocks whereas the more specific cardiac enzyme troponin T (TnT) would not.
Methods:
Patients admitted to our institution because of one or more ICD shocks were identified. Patients who had cardiac enzymes drawn within 24 hours of the last ICD shock were included. Clinical data were abstracted from medical records. Number of ICD shocks was obtained during interrogation of the ICD on admission. Correlation coefficients for the association between number of ICD shocks and cardiac enzyme level were calculated for the cardiac enzymes CK, CK-MB, and TnT. Results: A total of 73 patients with spontaneous ICD discharges and cardiac enzyme measurements were included. The mean age of patients was 68.1 years, and 54 (74%) were male. Mean peak CK was 371 +/-31 U/L, mean peak CK-MB was 22.1 +/-9 ng/ml, and mean peak TnT was 0.47 +/-0.8 ng/ml. Both peak CK (rho=0.34, p=0.005) and peak CK-MB (rho=0.41, p=0.004) were significantly correlated with the number of spontaneous ICD discharges delivered. However, there was no correlation between TnT and the number of spontaneous ICD discharges (rho=0.11, p=0.53). Of the 12 patients who had TnT above the upper limit of normal, 11 (91%) had known coronary disease. Conclusion: Although peak CK and peak CK-MB are correlated with the number of spontaneous ICD discharges, peak TnT is not. An elevated TnT in a patient who has received one or more spontaneous ICD discharges should not be attributed to delivered ICD shocks, but does warrant evaluation for ischemia.
1147-210
Implantable Cardiac Defibrillator Interactions With Magnetic Resonance Imaging at 1.5 Tesla James A. Coman, Jr., Edward T. Martin, David A. Sandler, J. Ryan Thomas, Oklahoma Heart Institute, Tulsa, OK, University of Oklahoma College of Medicine, Tulsa, OK Background: Implantable cardiac defibrillators (ICDs) are considered an absolute contraindication to magnetic resonance imaging and angiography (MRI/MRA). Only limited animal studies have been performed to assess the potential interactions between these devices. From our experience, pacemaker patients have undergone MRI scanning without difficulty. Given the design similarities, an assessment of the interaction between ICDs and MRI scanners was thought to be warranted and reasonable. Methods: Prospectively, 11 consecutive patients in need of cardiac, vascular and general MRI testing, with varied ICD models and leads, were scanned. Battery impedance, lead impedance, pacing threshold and sensing threshold were obtained prior to entering the 1.5 Tesla magnet. Tachydysrhythmia detection and therapy were disabled, while bradycardia therapy was left intact. Symptoms, non-invasive blood pressure and electrocardiographic signal were monitored continuously. Repeat ICD interrogation was performed after the scan. Defibrillation threshold testing was performed on all systems after the scan. Results: There were no episodes of loss-of-capture or device movement during the scan. Of the 14 leads scanned, none suffered a significant change in pacing threshold. No changes were seen in lead impedance or sensing thresholds. All systems had defibrillation thresholds that provided greater than the standard 10-Joule margin of safety. One patient reported mild heating around the defibrillator at the time of spin echo sequences. One patient experienced a brief, but asymptomatic, pause in pacing during scanning. One patient underwent scanning with his device 1 month into the elective replacement period. This device was found to be in a back-up mode after MRI scanning and could not be interrogated. The device was sent for destructive testing, at which time normal device function had returned. Circuit integrity was maintained. Conclusions: In 10 of 11 patients with ICDs, MRI and MRA scanning in a 1.5 Tesla magnet was found to be safe under carefully controlled conditions. MRI scanning of ICDs with low battery voltage may result in transient loss of function.
